Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. operates a health benefits and healthcare services platform built around affiliated health plans and the Carelon services business. Recurring company news covers Health Benefits results, premium yields, medical-cost trends, Medicaid, Medicare Advantage and employer group membership, and Carelon activity in pharmacy services, behavioral health, value-based care, care delivery, clinical, home health and complex care solutions.
Company updates also address small and midsize employer benefit offerings such as Balanced Funding and MEWAs, primary-care recognition and value-based provider programs, partnerships tied to family and community health, annual and quarterly financial guidance, and leadership changes across Health Benefits and Carelon.
Elevance Health (NYSE:ELV) is advancing mental health access by combining clinical programs, digital navigation and community partnerships, backing $23 million in active Elevance Health Foundation grants to support early intervention, prevention and care continuity nationwide.
Grants target state programs with concrete reach metrics (e.g., 47,600 Indiana youth, 3,617 Marin County individuals, 5,500 Virginia students) and operational tools to reduce crises, ER visits and total cost of care.
Elevance Health (NYSE: ELV) announced 45 primary care practices and health systems selected for its annual Care Provider Recognition Program on May 1, 2026.
The program honors the top 1% of primary care providers across Elevance Health’s affiliated network (~7,200 evaluated value-based partners), based on preventive care, immunizations, chronic disease management, medication adherence, and clinical learning.
Elevance Health (NYSE:ELV) says its affiliated health plans use Balanced Funding and MEWAs to help small businesses reduce and stabilize healthcare costs.
Company cites 26% healthcare cost rise for small businesses over five years, Kentucky MEWA savings of $400 million with 4,200 employers, and Ohio program savings of $1.3 billion serving 94,000 people.
Elevance Health (NYSE: ELV) reported 1Q 2026 operating revenue of $49.5 billion, up 1.5% year‑over‑year, and diluted EPS of $8.00 (adjusted diluted EPS $12.58).
The company raised FY 2026 adjusted diluted EPS guidance to at least $26.75 and set diluted EPS guidance at least $19.85, reaffirming FY operating cash flow of at least $5.5 billion. 1Q cash flow was $4.3 billion, and the quarter included a $935 million accrual for the CMS matter. The company returned $1.5 billion of capital to shareholders in 1Q.
Elevance Health (NYSE: ELV) announced leadership appointments across Health Benefits and Carelon on March 31, 2026, to strengthen execution, align capabilities, and drive growth.
Key moves include new presidents for Carelon Health, Carelon Insights, Government Business, and CFO appointments for Carelon and Health Benefits; Carelon serves 90+ million consumers and Health Benefits serves 45+ million members.
Elevance Health (NYSE: ELV) will release first quarter 2026 financial results on April 22, 2026 at 6:00 a.m. Eastern Daylight Time. Management will discuss results and outlook on a conference call at 8:30 a.m. EDT the same day.
The call is accessible by phone and a live webcast at the company website under Investors; a webcast replay will be available from 11:30 a.m. EDT on April 22, 2026, through May 22, 2026.
Elevance Health (NYSE: ELV) and the National Diaper Bank Network launched a 12-month national pilot to expand diaper access and study effects on maternal and child health. The program will distribute free diapers to up to 75 families per month at 10 Welcome Rooms, reaching as many as 9,000 families in 2026.
Sites span Bakersfield and Los Angeles, CA; Hialeah, FL; Columbia, MO; Lakewood, NJ; Columbus and Toledo, OH; Houston, TX; and two Washington, D.C. locations. NDBN will evaluate caregiver stress, preventive care access, financial strain, and links to family support services.
Elevance Health (NYSE: ELV) announced management changes to simplify decision-making and strengthen execution across Carelon and Health Benefits. Mark Kaye will expand CFO responsibilities to include oversight of Carelon. Felicia Norwood will lead a consolidated Health Benefits organization. Peter D. Haytaian will transition from President of Carelon effective May 4, 2026, and serve as Special Advisor through December 31, 2026.
The company said Carelon’s operating priorities and client commitments remain unchanged while the consolidation aims to improve coordination across Commercial and Government health benefits.
Elevance Health (NYSE: ELV) reported 4Q25 operating revenue of $49.3B and FY25 revenue of $197.6B. 4Q25 diluted GAAP EPS was $2.47 and adjusted EPS was $3.33; FY25 diluted GAAP EPS was $25.21 and adjusted EPS $30.29. The company returned $4.1B to shareholders in 2025 and announced FY26 guidance of at least $22.30 GAAP EPS and $25.50 adjusted EPS.
Revenue growth was driven by premium yields, acquisitions, and Medicare Advantage membership growth; benefit expense ratio rose to 93.5% in 4Q25. Carelon revenue increased 27% in 4Q25 to $18.7B.
Elevance Health (NYSE: ELV) will release its fourth quarter and full year 2025 financial results on January 28, 2026 at 6:00 a.m. EST. Management will discuss results and outlook on a conference call at 8:30 a.m. EST the same day. The call requires joining at least 15 minutes early and offers domestic and international dial-in numbers plus replay lines available from 11:30 a.m. EST on January 28, 2026 through February 27, 2026. A live webcast and webcast replay will be available via the company’s Investors page at elevancehealth.com.